Yoshioki Yamasaki

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 612 citations · Full text

Autoimmune Disease, Systemic Scleroderma, Immunology +3

Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis

Yoshioki Yamasaki, Hisakata Yamada, Masaomi Yamasaki et al. · Lara D. Veeken · 2006 · 208 citations · Full text

Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan

Yoshioki Yamasaki, Hidehiro Yamada, Michiko Ohkubo et al. · The Journal of Rheumatology · 2011 · 134 citations · Full text

Unusually high frequency of autoantibodies to PL‐7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis

Yoshioki Yamasaki, Hidehiro Yamada, Toshiko Nozaki et al. · Arthritis & Rheumatism · 2006 · 113 citations

Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis

Kohei Azuma, Hidehiro Yamada, Michiko Ohkubo et al. · Modern Rheumatology · 2010 · 84 citations

Amyopathic Dermatomyositis, Medicine, Predictive Factors +12